Treatment of non-metastatic castration-resistant prostate cancer: facing age-related comorbidities and drug–drug interactions

Taylor and Francis Group, Expert Opinion on Drug Metabolism and Toxicology, 9(18), p. 601-613, 2022

Journal article published in 2022 by David Conde-Estévez, Iván and Muñoz-Rodŕıguez Jesús Henríquez, Jesús Muñoz-Rodríguez, Alejo Rodriguez-Vida

Distributing this paper is prohibited by the publisher

Full text: Unavailable

Preprint: archiving forbidden

Postprint: archiving restricted

Upload

Published version: archiving forbidden

Policy details

Data provided by